Member Info for Paul2566

I've not been in PLUS long with an average of £13.7875, but I like what I've seen so far.

I'm just going to keep holding as its one of my defensive stocks.

My average is 46.86 so I'm still in the doledrums.
It would be nice to see 47p again.

Good old LGEN, its one of my keepers.

I'm holding to hedge against inflation, which should have a positive effect on banks.
I am averaging £4.1568 and intend to hold.

Not that I have seen.
I must confess I am unsure how I as a shareholder will benifit from the split.
I've held GSK for a while through good and bad, so I will continue to keep the faith.

I'm not against share buy back, but with the inflation cloud on the horizon, debt reduction may protect profits better.
However the board are not fools, so there will be tactical reasons for their decisions.
I bought this stock as I believe it to be a well managed company, so I'm happy to just let them get on with what they are paid to do.

Thank goodness for that.
While I am a believer in the need to transition to greener energy, give BP time to do so.

Same here, divi reinvested in a Halifax ISA.
Who dosen't love free money.

This is one of my portfolio anchors, I can't see any chance I wont be holding this at around 5% of my portfolio value.

I bought ADM stock a while back, mostly for the dividend.
423 shares at £29.1286. I liked the buisness then and haven't changed my view.
The markets are not happy at the moment, but I bought this to hold for 10 years, and unless the business model changes for the worst, I will hold through any dips. I do love a divi.

If you examine the FTSE100 market in broad terms you will find most stocks are down today. My portfolio of 21 stocks has been up and down by as much as £3600 a day. But over the last 3 weeks its up just under £1k. The market is very skittish at the moment. Covid, inflation and Evergrande have spooked investors.
If Evergrande fails it will have a knock on effect to its creditors, and that could easily be enough to instigate a market crash. $89 billion US debt is going to hurt the market, but hopefully it wont come to that, but remember Lehman Brothers.

What big sale?
The biggest sale today so far has been 650,000 shares. If you examine the SP. This had no effect on the SP, which isn,t surprising given the number of shares in circulation.
There are no professional investors who have any interest in this at the moment, there area few holding longer term but they are not adding or selling at the moment.

If they are the house broker for MGC, they are unlikly to give a poor SP target, MGC would probably take a dim view.

Broker targets are not very reliable, and the brokers relationship with the company in question can and does have an effect on their predictions. I am not aware of any relationship between MXC and the broker as I haven't bothered to look into it.
Multiple predictions from various brokers may give an indication to direction, but 1 broker does not a summer make.

In good humor and amusing none the less

Why?
The US deal was already factored into the SP, with recent drops likely due to lack of news regarding the deal which was expected by 1st October, instutional investors would probably be unphased by the delay but due to the disproportional number of PI's this in my view is why we saw the drop.
The deal its-self I view as a drop in the ocean and still does not cover MXC outgoings, however its true value is its exposure to the US market and the impact it could have on product in development not yet come to market. I personally view this aspect of the deal as potentially very important indeed.

I suspect there are a few here who have not read this, so for ease here are a few highlights.
It has been authorised for release by MGC, who are also the source of its content.

Current shareholder breakdown;
Directors/Management......................................4%
UK Retail Investors.............................................9%
UK Instutional Funds and Family Offices........25%
Independant Shareholders..............................62%

Ordinary Shares 2,403,495,855
Performance Rights 97,500,000
Unlisted Options & Convertible Notes($0.026-$0.07) 85,432,986
Convertible Notes 2,100,000

Cash at bank $5,400,000

CannEpil - Currently in phase IIb clinical trial - No information on time to market.
CogniCann - Currently in phase II clinical trial - No information on time to market.
CimetrA - Approved for phase III clinical trial - Patient recruitment underway, trial not commenced - No information on time to market.
CannEpil - Expected time to market authorisation 4 years.
CogniCann - Expected time to market authorisation 5 years.
CimetraA - Expected time to market authorisation less than 1 year.
CepaCann - Preclinical in process.
Tetrinol - Preclinical in process.
MXOTO1GB01 - Preclinical in process. Phase I planned H2 2021.
MXOTO2ME01 - Preclinical in process.
MXOTO3PC01 - Preclinical in process.
InCann - Preclinical in process. Phase I planned H2 2021.
TopiCann - Study results: 70% effective within 4 weeks.

Slovenian manufacturing facility capable of producing 12,000 products per month.
Malta manufacturing facility online October 2021 capable of producing 188,000 products per month.

Its worth a read for those invested, and it can be seen that investments in MXC should have a medium term (5 year ) investment horizon.

Still no indication on how and where further funding will come from.
Its obvious it will be required very soon and it would be nice to know.

Wednesday ?

Best buy price so far today 2.943p, still waiting.